The Nerve Growth Factor (NGF) Discovery Experiments – Rita Levi-Montalcini and Stanley Cohen

The history of modern neurobiology is defined by a series of conceptual transformations that systematically dismantled the view of the nervous system as an immutable, structurally hardwired apparatus. In the first half of the twentieth century, embryologists and anatomists viewed the developing embryo through the lens of mechanical constraints, inductive structural templates, and rigid genetic determinism. The mechanisms that guided billions of axons toward their precise peripheral targets, that determined which neuronal subpopulations survived the gauntlet of morphogenesis, and that established functional synaptic circuits were wrapped in speculative morphological theories. It was widely assumed that physical pathways, mechanical tensions, or non-specific physiological electrical resonances dictated the architectural trajectory of growing nerves.

The discovery of Nerve Growth Factor (NGF) by Italian developmental neurobiologist Rita Levi-Montalcini and American biochemist Stanley Cohen fundamentally revolutionized this paradigm. Working first in isolation amidst the existential horrors of Fascist Italy and World War II, and later within the vibrant intellectual crucible of Washington University in St. Louis, Levi-Montalcini dismantled prevailing dogmas regarding neuronal differentiation and survival. She demonstrated that developing neurons are not mechanically steered or unconditionally committed to live, but are instead dependent upon retrograde, chemical instructions secreted in minute, limiting quantities by their peripheral target fields.

When Stanley Cohen joined Levi-Montalcini in the laboratory of embryologist Viktor Hamburger, their interdisciplinary union synthesized classical experimental embryology with rigorous, cutting-edge analytical biochemistry. Their systematic isolation of NGF—from mouse sarcomas, snake venom, and mammalian salivary glands—unveiled the archetype for an entire superfamily of signaling molecules now recognized as neurotrophins and growth factors. This discovery earned Levi-Montalcini and Cohen the 1986 Nobel Prize in Physiology or Medicine. The empirical narrative of NGF’s discovery represents one of the most intellectually compelling, technically rigorous, and historically dramatic odysseys in the history of biomedical science.

1. Historical Context and Early Paradigms in Neuroembryology

1.1 The Pre-NGF Neurobiological Landscape

At the dawn of the twentieth century, neuroembryology was locked in an intense debate concerning the fundamental nature of axonal outgrowth and directional pathfinding. Following the definitive establishment of the Neuron Doctrine by Santiago Ramón y Cajal—which posited that the nervous system is composed of discrete, individual cellular units rather than a syncytial reticular network—investigators confronted a perplexing question: by what physical or chemical means do these autonomous, delicate protoplasmic extensions negotiate the complex, three-dimensional terrain of the developing embryo to innervate their distant peripheral targets?

Two primary conceptual schools emerged to explain this developmental marvel. The first school, anchored in structural mechanics and embryological physics, was heavily championed by researchers such as Wilhelm His and later refined by Ross Granville Harrison. In 1907, Harrison developed the revolutionary hanging-drop tissue culture technique, demonstrating unequivocally that the nerve fiber originates as an amoeboid protoplasmic outgrowth from a single neuroblast, capable of autonomous elongation without pre-existing syncytial bridges. However, Harrison’s work also underscored the profound reliance of growing axons on physical micro-substrates. The growth cone required solid or semi-solid physical supports—such as fibrin networks, spider webs, or glass coverslips—along which it could pull itself forward. This observation laid the groundwork for the theory of stereotropism, or mechanical contact guidance, which suggested that micro-grooves, fascial planes, and tissue interfaces mechanically direct axons toward their final destination.

Conversely, Santiago Ramón y Cajal had articulated the intuitive “neurotropic hypothesis” as early as 1893. Drawing inferences from the exquisite morphology of axonal growth cones observed in static silver-impregnated histological preparations, Cajal hypothesized that peripheral tissues, embryonic guidepost cells, or target organs emit chemoattractive substances. These soluble chemical emanations were thought to diffuse through the intercellular matrix, creating a concentration gradient that the sensitive, filopodial apparatus of the growth cone could detect and navigate toward via positive chemotropism. Cajal’s hypothesis was conceptually brilliant, anticipating the molecular guidance cues discovered nearly a century later. However, at the time of its articulation, it remained entirely devoid of direct biochemical evidence, rendering it vulnerable to fierce criticism from mechanistic experimentalists who viewed chemical attraction over long embryonic distances as speculative and physically implausible.

By the 1930s and 1940s, the conceptual pendulum had swung aggressively toward non-chemical, structural paradigms, largely under the forceful intellectual leadership of Austrian-born biologist Paul Weiss. Weiss developed the influential “resonance principle” and the doctrine of “contact guidance.” Rejecting Cajal’s neurotropic hypothesis as mystical and teleological, Weiss asserted that axonal pathfinding and terminal connectivity were governed entirely by the mechanical ultrastructure of the submicroscopic ground substance. According to Weiss, physical stresses, tensions, and fluid currents within the developing extracellular matrix oriented the macromolecular micellar infrastructure of embryonic tissues. Axons simply followed these oriented physical pathways through thigmotaxis, much like water flowing through carved trenches.

Furthermore, Weiss’s resonance principle proposed that peripheral organs did not instruct or attract specific nerve fibers during development. Instead, he argued that axons innervated peripheral structures haphazardly and non-selectively; the target muscle or sensory organ subsequently “tuned” or conditioned the innervating neuron through a process of retroactive modulation, establishing functional resonance without requiring predetermined biochemical affinity. This mechanically dominated, anti-humoral paradigm held an almost dogmatic grip over early-to-mid-twentieth-century neuroembryology, creating an inhospitable conceptual climate for any theory that relied upon soluble, diffusible chemical messengers.

1.2 Quantitative Neuroembryology and Target-Dependent Survival

Parallel to the debates regarding axonal pathfinding, experimental embryologists sought to decipher the quantitative relationships that govern peripheral tissue mass and the size of corresponding central and peripheral neural centers. It had long been recognized from pathological human specimens and comparative anatomical dissections that animals possessing massive peripheral structures (such as the hypertrophied limbs of ungulates or the electric organs of gymnotid fish) exhibited correspondingly enlarged motor and sensory spinal ganglia. Conversely, the congenital absence or experimental amputation of a limb resulted in dramatic hypoplasia of the associated neural centers.

In 1909, Marian Shorey initiated the field of experimental quantitative neuroembryology by systematically amputating the limb buds of embryonic chicks and observing the subsequent reduction in the size of the corresponding lateral motor columns and sensory dorsal root ganglia (DRG). Decades later, during the early 1930s, German-born embryologist Viktor Hamburger, working in the Department of Zoology at Washington University in St. Louis, transformed Shorey’s basic surgical paradigm into a rigorous, quantitative experimental science. Hamburger, who had trained under the legendary embryologist Hans Spemann, brought the sophisticated techniques of Spemann’s experimental mechanics to the study of the avian nervous system.

In a seminal series of experiments published in 1934, Hamburger excised the prospective wing-buds of chick embryos at approximately 2.5 to 3 days of incubation (stages 17–19 of the Hamburger-Hamilton staging series), long before functional neuromuscular junctions or sensory contacts were established. Following further development, Hamburger meticulously harvested the embryos, fixed them, prepared serial histological cross-sections, and conducted quantitative volumetric measurements of the spinal cord’s lateral motor columns and sensory ganglia. His findings were striking: the removal of the peripheral limb target resulted in a marked reduction—up to 50 to 60 percent—in the cross-sectional area and cell volume of both the motor horn and the associated sensory dorsal root ganglia.

To explain this striking peripheral control over central neuronal mass, Hamburger formulated what became known as the “recruitment hypothesis” (or the inductive differentiation hypothesis). Influenced heavily by Spemann’s paradigm of embryonic induction, Hamburger conceptualized the peripheral target as an active inductive organizer. He proposed that the nascent limb bud sent retrograde, organizing stimuli centripetally into the developing spinal cord and ganglia. These stimuli were thought to “recruit” morphologically indifferent, pluripotent neuroblasts, compelling them to differentiate into mature, axon-bearing nerve cells. In the absence of the limb bud, this inductive signal was missing; consequently, Hamburger argued, the primordial neuroblasts failed to divide, failed to differentiate, and simply regressed or remained as unspecialized, arrested cellular precursors.

Hamburger’s hypothesis possessed an elegant logical coherence that aligned cleanly with the dominant inductive embryology of the Spemann school. However, it suffered from profound theoretical and empirical limitations imposed by the methodologies of classical histology. Fixed, static tissue sections stained with standard histological dyes could reveal cellular volume, spatial arrangement, and nuclear morphology, but they were entirely incapable of capturing the real-time dynamic life histories of individual cells. Hamburger could observe an end-stage deficit of differentiated neurons in the hypoplastic ganglia, but he could not directly visualize the physiological processes—whether proliferation, arrested maturation, or active cellular destruction—that produced that deficit. The fundamental biochemical mechanisms mediating target-dependent neuronal scaling remained entirely obscure, sealed within the unyielding confines of descriptive, non-molecular histology.

2. Rita Levi-Montalcini: Clandestine Research and Chick Embryo Studies

2.1 Academic Exile and the Bedroom Laboratory in Turin

The trajectory of neuroembryological discovery was radically altered not in an elite university research center, but within the domestic confines of a private bedroom in northern Italy, driven by political oppression and war. In 1938, the Italian Fascist regime under Benito Mussolini promulgated the catastrophic anti-Semitic Manifesto della Razza (Manifesto of Race), followed swiftly by royal decrees that stripped Italian citizens of Jewish ancestry of their civic, professional, and academic rights. Rita Levi-Montalcini, a brilliant young medical doctor and neurohistologist who had graduated with highest honors from the prestigious Institute of Human Anatomy at the University of Turin, was abruptly terminated from her position as an assistant to the celebrated anatomist and histologist Giuseppe Levi.

Barred from access to university laboratories, academic libraries, and professional medical practice, Levi-Montalcini refused to abandon her scientific calling. Inspired by the example of Belgian neuroembryologist Jean Brachet, who had continued his cytological investigations under adverse circumstances, she resolved to construct a fully functioning, clandestine embryological research laboratory directly inside her bedroom at her family’s home in Turin. Utilizing rudimentary tools adapted from domestic life and non-academic trades, she assembled an experimental apparatus that was both a marvel of improvised engineering and a profound act of intellectual resistance.

Her surgical instruments were fashioned from ordinary sewing needles sharpened against Arkansas whetstones, watchmaker’s forceps, and tiny ophthalmological scissors. For microtomy, she relied upon a simple, manually operated microtome obtained through sympathetic non-Jewish colleagues, which she mounted onto a solid wooden domestic table. Incubation of fertile chicken eggs was accomplished using a converted domestic warming box or a simple egg incubator purchased from local agrarian suppliers, its internal temperature regulated through calibrated incandescent light bulbs and primitive bi-metallic thermostats. Eggs were sourced from local farmers, transported covertly through the streets of Turin under the pretext of providing nutritional sustenance for an infant.

Within this clandestine space, Levi-Montalcini operated on hundreds of chick embryos. She developed extraordinary microsurgical dexterity, cutting tiny windows through the calcified eggshells with a dental drill or a sharp sewing needle, operating on embryonic blastoderms through the open window under a basic monocular dissection microscope, and sealing the shell apertures with molten paraffin wax before returning the embryos to their improvised incubation chambers. To visualize the microscopic nervous system with exquisite resolution, she adapted the classic silver impregnation techniques developed by Santiago Ramón y Cajal and Fernando de Castro. This delicate, capricious histological procedure involved prolonged tissue fixation in chloral hydrate, followed by immersion in silver nitrate solutions and subsequent chemical reduction with pyrogallol or hydroquinone, precipitating metallic silver grains onto the neurofibrils of developing axons. Despite the constant threat of aerial bombardment by Allied forces and the ever-present danger of discovery by Fascist authorities and the Gestapo, Levi-Montalcini pursued her experiments with obsessive, monastic discipline, later joined by her former mentor Giuseppe Levi, who had also been stripped of his professorship and sought shelter in Turin.

2.2 Re-evaluating Hamburger’s Hypotheses: Discovery of Naturally Occurring Cell Death

Working in intellectual isolation, Levi-Montalcini’s immediate experimental focus was the critical replication and re-evaluation of Viktor Hamburger’s 1934 limb-bud extirpation papers, which she had read before the enforcement of the racial laws. However, when she performed unilateral wing-bud extirpations on chick embryos and systematically analyzed the sensory dorsal root ganglia and lateral motor columns via serial silver-impregnated sections, her observations diverged fundamentally from Hamburger’s recruitment model.

Where Hamburger had concluded that the periphery sent an inductive signal promoting the initial differentiation of neuroblasts, Levi-Montalcini’s meticulously timed serial sections revealed a startlingly different chronological sequence. She observed that during the initial stages following the surgical ablation of the wing-bud (between 3.5 and 5 days of incubation), the sensory ganglia and lateral motor columns on the operated side developed with total histological normality. Indifferent neuroblasts proliferated through active mitotic division at rates precisely indistinguishable from the contralateral, intact control side. These neuroblasts differentiated, extended axons out toward the amputated periphery, and formed initial ganglionic architectures that were morphologically identical to the uninjured control side.

The divergence between the operated and unoperated sides did not occur at the onset of differentiation, but only later—precisely when the growing axonal trajectories arrived at the periphery and discovered that their target tissue was missing. At this critical developmental juncture (between days 5 and 7 of incubation), Levi-Montalcini observed an unprecedented, massive wave of cellular degeneration within the sensory ganglia and lateral motor columns. Under the high-power objective of her light microscope, she documented the unambiguous, classical cytological hallmarks of cellular death: the condensation of chromatin into dense, hyperchromatic spherical masses (pyknosis), followed by cytoplasmic shrinkage, nuclear fragmentation (karyorrhexis), and the eventual clearance of the cellular debris by surrounding phagocytic microglial-like cells.

Even more critically, when Levi-Montalcini scrupulously examined the histological sections of normal, unoperated control chick embryos, she detected the exact same pyknotic degenerate profiles within the sensory ganglia and spinal cord, albeit at a lower baseline frequency. This was a profound, paradigm-shattering insight: cell death was not merely a pathological artifact of surgical trauma, but an intrinsic, naturally occurring physiological event in normal neurogenesis. The developing embryo naturally overproduced neurons, sending a vast surplus of axons toward the peripheral target field; the periphery did not “induce” neuroblasts to differentiate, but rather sustained and preserved the survival of only a fraction of those neurons that successfully established physical or metabolic connections with the target tissue.

In a series of landmark papers authored with Giuseppe Levi and published between 1942 and 1944—first in the Belgian journal Archives de Biologie (since Jewish authors were strictly forbidden from publishing in Italian or German scientific journals) and later in Vatican and Swiss publications—Levi-Montalcini formulated the foundational principles of modern target-dependent neuronal survival. She concluded that the peripheral limb bud did not act as an inductive, recruitment organizer, but as a trophic sanctuary. It provided a life-sustaining, retroactive influence that shielded nascent neurons from an otherwise pervasive, cell-intrinsic programmatic demise. These wartime papers laid the direct conceptual framework for what would later be formalized as retrograde neurotrophic signaling.

3. The Hamburger Collaboration and the Washington University Crucible

3.1 The Invitation to St. Louis

Following the liberation of Northern Italy in 1945 and the conclusion of World War II, the fractured global channels of scientific communication slowly reopened. In St. Louis, Missouri, Viktor Hamburger finally gained access to the European biological journals published during the conflict. As he read the 1942 and 1944 papers of Levi-Montalcini and Levi, Hamburger was immediately struck by the intellectual rigor, technical mastery, and devastating histological clarity of their critique. Rather than retreating into defensive academic dogma to protect his 1934 recruitment hypothesis, Hamburger exhibited an exceptional intellectual generosity and scientific objectivity. He recognized that Levi-Montalcini had uncovered an entirely new developmental dynamic that exposed the analytical limitations of his earlier interpretations.

In late 1946, Hamburger sent a formal letter to Levi-Montalcini in Turin, extending an invitation for her to spend a temporary, six-month research fellowship in his laboratory at the Department of Zoology at Washington University in St. Louis. The objective was straightforward: to join forces, standardize their microsurgical and histological methodologies, and definitively resolve the theoretical dispute regarding whether peripheral targets mediated their effects through the recruitment of undifferentiated neuroblasts or through the trophic maintenance of already-differentiated neurons.

Rita Levi-Montalcini arrived in St. Louis in the autumn of 1947, entering an experimental environment vastly different from her improvised domestic bedroom laboratory. Washington University offered well-equipped facilities, climate-controlled incubators, precision microtomes, superior optical microscopes, and a vibrant community of developmental biologists. What was originally intended as a brief six-month collaborative visit stretched into a historic academic association that would span three decades.

Working closely together at the laboratory bench, Levi-Montalcini and Hamburger repeated the wing-bud extirpation and limb-bud grafting experiments on a massive, statistically rigorous scale. They standardized the Hamburger-Hamilton chick embryo staging system to eliminate developmental variability, employed meticulous silver impregnation methods alongside classic nuclear counterstains, and conducted exhaustive, quantitative counts of mitotic figures, pyknotic degenerative nuclei, and surviving mature neurons. The results of this collaborative tour de force were published in 1949 in a monumental paper in the Journal of Experimental Zoology. The paper formally settled the scientific debate: Hamburger openly abandoned his original recruitment hypothesis, fully endorsing Levi-Montalcini’s conclusion that peripheral targets regulate the size of their innervating neuronal populations strictly by determining the proportion of differentiated neurons that survive a massive wave of naturally occurring physiological cell death.

3.2 The Search for an Exogenous Biological Signal

While the 1949 Levi-Montalcini and Hamburger paper definitively validated the trophic concept of target-dependent survival, the actual biological nature of this trophic influence remained completely obscure. Was the survival signal a physical, metabolic, or biochemical factor? Investigating this question within the context of normal embryogenesis presented near-insurmountable technical hurdles. Normal embryonic limb buds are complex, heterogeneous mosaics composed of differentiating chondrocytes, myoblasts, connective tissues, and epidermis, all present in minute, microscopic quantities. Isolating a hypothetical trophic chemical from these fragile, microscopic tissue masses using contemporary mid-twentieth-century biochemical tools was virtually impossible.

The critical breakthrough that rescued the field from this empirical impasse emerged from a surprising, highly unorthodox experiment conducted by a former graduate student of Hamburger’s, Elmer Bueker. In 1948, Bueker sought to determine whether rapidly proliferating neoplastic tissues could serve as a functional substitute for the rapidly dividing mesenchyme of an embryonic limb bud. Using standard microsurgical techniques, Bueker ablated the right hind-limb bud of a 3-day-old chick embryo and implanted into the resulting surgical deficit a small, viable fragment of a mouse tumor: Sarcoma 180, a fast-growing, highly undifferentiated malignant neoplasm maintained through serial passage in laboratory rodents.

When Bueker harvested and histologically examined the embryos after several days of incubation, he observed a remarkable phenomenon. The mouse tumor graft had integrated seamlessly into the chick embryo’s body wall, rapidly expanding into a substantial, vascularized neoplastic mass. When silver-stained sections were examined, Bueker discovered that the sensory dorsal root ganglia located adjacent to the tumor (specifically DRG 24 to 28) had enlarged significantly—exhibiting an approximate 30 to 40 percent increase in volume compared to the contralateral, non-tumor-bearing control ganglia. Furthermore, dense streams of sensory nerve fibers had emerged from these hypertrophied ganglia and invaded the malignant tissue.

However, Bueker’s interpretation of these findings remained firmly rooted in the mechanical, non-chemical paradigms of the era. He noted that while sensory axons heavily innervated the Sarcoma 180 tissue, the adjacent motor nerve fibers of the spinal cord’s lateral motor columns completely failed to penetrate the neoplastic mass. Bueker concluded that Sarcoma 180 merely provided a favorable, highly cellular physical matrix or growth terrain—a permissive “growth substrate”—that selectively accommodated sensory axon elongation through superior mechanical contact guidance. He viewed the tumor simply as an exceptionally expansive, rapidly growing target tissue that non-specifically absorbed sensory axons through passive stereotropism.

When Rita Levi-Montalcini read Bueker’s 1948 paper, she perceived an entirely different, revolutionary reality. Where Bueker saw a passive physical scaffold, Levi-Montalcini recognized an active, hyper-secreting biological factory. She was stunned by the sheer magnitude of the ganglionic enlargement Bueker had documented and noted an essential clue that Bueker had overlooked: normal embryonic limb-bud tissues never provoked such an explosive, uncontrolled neural reaction. Sarcoma 180, she hypothesized, was not merely a passive substrate; it was an exogenous, hyperactive source of a potent, specific biochemical substance that was driving the explosive growth, precocious differentiation, and target-dependent survival of specific neural populations. Levi-Montalcini immediately persuaded Hamburger to let her replicate and radically expand Bueker’s tumor grafting experiments.

4. The Sarcoma Grafting Experiments: Serendipity and Mechanistic Insight

4.1 Transplantation of Sarcoma 180 and Sarcoma 37

Between 1949 and 1951, Rita Levi-Montalcini, working in Hamburger’s St. Louis laboratory, embarked on a series of experimental tumor transplantations into chick embryos that produced some of the most spectacular, bizarre, and revealing histological images in the history of embryology. Instead of merely substituting the tumor for an ablated limb bud as Bueker had done, Levi-Montalcini transplanted fragments of mouse Sarcoma 180 and another highly aggressive murine tumor, Sarcoma 37, into diverse, non-amputated anatomical regions of 3-day chick embryos. Tumor fragments were inserted into the intra-embryonic coelomic cavity adjacent to embryonic viscera, onto the lateral body wall, and even into ectopic locations that had no physical contact with normal neurogenic pathways.

The histological results were stunning. The presence of the mouse sarcoma fragments induced an unprecedented, explosive neurogenic response that far exceeded anything previously recorded in experimental embryology. The sensory dorsal root ganglia directly facing the tumor underwent massive, pathological hypertrophy and hyperplasia, ballooning to several times their normal physiological volume. But the most dramatic, totally unforeseen effect was observed in the sympathetic nervous system. The paravertebral and prevertebral sympathetic chain ganglia that were adjacent to, or even located at significant distances from, the implanted tumor expanded to colossal dimensions—often reaching four to six times the volume of the corresponding contralateral ganglia.

The behavior of the growing nerve fibers was even more astonishing. Dense, massive bundles of sensory and sympathetic axons burst forth from the hypertrophied ganglia, forming chaotic, tangled neuromatous networks that aggressively invaded the mouse tumor. Axons did not merely terminate within the tumor tissue; they formed a dense, turbulent fibrillar plexus that enveloped neoplastic cells. Most remarkably, this axonal growth spilled out beyond the boundaries of the tumor. Giant streams of sympathetic axons invaded adjacent, normally non-innervated embryonic tissues: they aggressively penetrated the mesonephric tubules of the embryonic kidney, infiltrated the parenchyma of the liver, wrapped themselves around the walls of embryonic blood vessels, and actually bored directly through the endothelial linings of large veins, protruding into the blood lumen in naked, microscopic neurovascular cascades.

Crucially, this explosive neurogenic phenomenon was accompanied by absolute neuronal selectivity. Despite the massive hyper-innervation of sensory and sympathetic fibers, the adjacent motor neurons of the spinal cord’s lateral motor columns exhibited complete indifference. Their axons passed by the tumor along normal trajectories, completely failing to enter the neoplastic mass or undergo any degree of somal hypertrophy or hyperplasia. This exquisite differential responsiveness provided undeniable proof that the tumor did not act through non-specific mechanical pathways or generalized metabolic stimulation; it possessed a highly selective biological specificity, targeting exclusively sensory and sympathetic neural lineages.

4.2 Divergence from Classical Neurotropic Paradigms

As Levi-Montalcini performed thousands of serial cross-sections of these tumor-grafted embryos, she documented a series of critical empirical observations that completely shattered the classical neurotropic and mechanical guidance paradigms. The prevailing models demanded physical contact: for an axon to be guided or for a neuron to be modified by a target, the axonal growth cone supposedly had to physically interact with the target’s physical substratum or its local extracellular matrix.

Levi-Montalcini discovered that physical contact was completely unnecessary. Through meticulous temporal histological profiling, she proved that the sympathetic and sensory ganglia began to enlarge, undergo accelerated mitotic division, and exhibit precocious cellular differentiation long before the growing pioneer axons made any physical contact with the transplanted tumor tissue. The neural response was clearly initiated at a distance. Furthermore, sympathetic ganglia that were completely isolated from the tumor by physical anatomical barriers, or located several segments away from the neoplastic mass, exhibited profound, generalized hypertrophy. The cells within these distant ganglia displayed accelerated enlargement of their cytoplasm, expansion of their nucleoli, accelerated Nissl substance synthesis, and premature extrusion of axons.

To eliminate the possibility that this phenomenon was simply an unselective biological reaction to the presence of rapidly growing foreign tissue, Levi-Montalcini performed a vast battery of rigorous negative control experiments. She implanted various rapidly growing embryonic chick tissues (such as heart, liver, mesonephros, and limb mesenchyme) directly into identical coelomic positions. None of these normal somatic grafts provoked the slightest degree of ganglionic hypertrophy or ectopic hyper-innervation. She then grafted other neoplastic tissues, including mouse adenocarcinoma and various non-sarcomatous tumors; these also failed to replicate the hyper-neurogenic phenomenon. The effect was uniquely restricted to specific malignant lines, primarily mouse Sarcoma 180 and Sarcoma 37.

From these rigorous observations, Levi-Montalcini derived a bold, definitive conclusion. The tumor was releasing a soluble, diffusible chemical agent into the embryonic tissue fluids. This agent possessed the unique property of selectively stimulating the survival, differentiation, and fiber outgrowth of sensory and sympathetic neurons. The classical concepts of contact guidance, mechanical resonance, and local substrate traction were wholly incapable of explaining the phenomena unfolding beneath her microscope. The data demanded the conceptualization of a potent, tumor-derived, humoral neurotrophic factor.

5. Conceptualization of a Diffusible, Humoral Neurotrophic Factor

5.1 The Chorioallantoic Membrane (CAM) Experiments

Despite the compelling histological evidence gathered from intra-coelomic graft experiments, the broader community of embryologists remained deeply skeptical. Led by traditionalists like Paul Weiss, critics argued that intra-embryonic tumor grafts inevitably caused severe localized anatomical distortions, mechanical compressions, and alterations in embryonic tissue tension. They asserted that the observed axonal sprouting and ganglionic enlargement could still be explained by abnormal mechanical stress fields or specialized extracellular matrix tracks laid down by the invasive sarcoma cells.

To decisively dismantle these mechanical counter-arguments, Levi-Montalcini conceived an experimental design of absolute surgical and physiological elegance: the chorioallantoic membrane (CAM) transplantation experiment. The chorioallantoic membrane is an extra-embryonic vascular membrane that lines the inner surface of the eggshell in avian species, functioning primarily as the embryo’s respiratory and waste-exchange organ. Critically, the CAM is completely devoid of nervous tissue; no sensory or sympathetic axons from the embryo proper extend into the distant vascularized territory of the CAM.

In 1952, Levi-Montalcini surgically opened 4- to 5-day-old chick eggs and implanted fragments of Sarcoma 180 directly onto the outer surface of the vascularized CAM. The tumor rapidly established local vascular connections with the extra-embryonic blood vessels, flourishing and expanding into a massive neoplastic nodule completely physically isolated from the embryo proper. The only physiological conduit linking the tumor to the distant embryonic body was the circulating extra-embryonic bloodstream.

When the host embryos were sacrificed, serially sectioned, and examined several days later, the results were definitive. Even though the tumor was situated entirely outside the physical borders of the embryo, with centimeters of vascular and fluid separation and zero physical nerve contact, the embryonic nervous system exhibited a spectacular, systemic transformation. The sympathetic chain ganglia throughout the entire length of the embryo—from the cervical region to the sacral segments—were hyperplastic and hypertrophied to a monstrous degree. The sympathetic axons had erupted into a state of wild, unchecked hyper-innervation, penetrating nearly every internal visceral organ and choking the lumen of the cardinal veins and major arteries with neurofibrillar webs.

The CAM experiments completely eliminated every conceivable mechanical, physical, or contact-guidance counter-explanation. There was no physical pathway, no oriented fibrillar matrix, and no mechanical tension field connecting the tumor on the CAM to the sympathetic ganglia deep within the embryo’s coelom. The active agent had to be a soluble, diffusible, humoral chemical substance. It was synthesized by the tumor cells, secreted into the extra-embryonic capillary beds, transported through the embryonic circulation, and delivered systemically to the receptive sensory and sympathetic neuroblasts, where it bound to specific targets to drive cellular growth and survival.

5.2 Defining the ‘Neurotrophic’ Concept

The success of the CAM experiments forced a profound conceptual reassessment of the mechanisms governing neural development. Up to this point, embryonic signaling had been viewed almost exclusively through the prism of embryonic induction—short-range, temporally circumscribed interactions where an organizer tissue instructs an uncommitted cell population to adopt a specific developmental fate. Once induced, the cell was assumed to be autonomous.

Levi-Montalcini recognized that the tumor factor represented a completely different category of biological agent: a truly “neurotrophic” molecule. The term trophic (derived from the Greek trophe, meaning “nourishment” or “sustenance”) had occasionally been employed in neurophysiology to describe non-electrical regulatory interactions between nerves and target muscles. Levi-Montalcini expanded and redefined this concept into a comprehensive developmental paradigm. A neurotrophic factor was not an inductive switch that initiated identity, nor was it a classical neurotropic guidance cue that physically tugged an axon through space. Instead, it was an ongoing, target-derived metabolic requirement—a specific survival factor operating at nanomolar or picomolar concentrations that neurons continually required to avert programmatic cellular death and to maintain their morphological complexity.

This formulation met severe resistance from the traditional embryological establishment. The idea that a specific, diffusable chemical signal could orchestrate the precise quantitative architecture of the peripheral nervous system seemed to many contemporary embryologists an unnecessary, radical departure from classical morphological mechanics. Moreover, embryologists pointed to an enormous empirical void: the factor was entirely hypothetical. No one had isolated it, no one knew its chemical composition, and its mechanism could not be studied dynamically within the complex, confounding milieu of an intact living embryo.

Levi-Montalcini recognized that as long as her experimental system remained chained to the whole chick embryo—requiring days of incubation, intricate microsurgery, serial paraffin sectioning, and arduous histological quantification—the biochemical isolation and characterization of the active factor would remain impossible. What was urgently required was an isolated, highly sensitive, rapid in vitro bioassay that could decouple the neurotrophic phenomenon from systemic embryonic physiology and provide a quantitative readout of biological activity within hours rather than weeks.

6. The In Vitro Bioassay Breakthrough in Rio de Janeiro

6.1 Hertha Meyer’s Laboratory and Tissue Culture Innovation

Driven by the pressing need to develop an in vitro tissue culture assay, Rita Levi-Montalcini sought out the expertise of Hertha Meyer, an internationally renowned tissue culture expert and a fellow scientific refugee from Nazi Germany. Meyer directed an advanced tissue culture laboratory at the Instituto de Biofísica, directed by Carlos Chagas Filho, at the University of Brazil in Rio de Janeiro. In the autumn of 1952, Levi-Montalcini embarked on a transatlantic journey to South America, carrying in her overcoat pocket two laboratory mice bearing subcutaneous implants of Sarcoma 180—the living biological source from which the mystery of nerve growth would be unlocked.

Upon arriving in Rio de Janeiro, Levi-Montalcini and Meyer immediately set to work adapting the classic “hanging-drop” tissue culture technique to the study of embryonic ganglia. The technical protocol required rigorous optimization of chemical and physiological parameters. The culture substrate consisted of a semi-solid biological clot formed by mixing a drop of adult chicken blood plasma with a drop of crude embryonic chick extract diluted in Tyrode’s balanced salt solution, situated upon a thin glass coverslip inverted over the shallow cavity of a depression slide.

Under a dissecting microscope, Levi-Montalcini micro-dissected dorsal root ganglia and sympathetic chain ganglia from 7-to-9-day-old chick embryos with surgical precision. She explanted these intact, microscopic ganglia onto the plasma clot, positioning them a mere one to two millimeters away from a similarly dissected fragment of mouse Sarcoma 180 tissue. Parallel negative control cultures were prepared in which ganglia were explanted either entirely alone or adjacent to fragments of normal embryonic tissue, such as heart or liver mesenchyme. The inverted culture slides were sealed with molten paraffin to prevent desiccation and incubated at 37.5 degrees Celsius.

6.2 The ‘Halo’ Effect: A Semiquantitative Phenomenon

The experimental outcome exceeded Levi-Montalcini’s wildest expectations. When she pulled the first experimental slides from the incubator and mounted them under the light microscope after a mere 12 to 24 hours of incubation, she observed an unprecedented biological spectacle. While the control ganglia cultured alone or with normal heart tissue exhibited only a sparse, sluggish extrusion of a few wandering axons accompanied by a disorganized sheet of migrating, non-neuronal spindle-shaped fibroblasts, the ganglia cultured adjacent to the Sarcoma 180 fragment had undergone an explosive, symmetrical transformation.

Surrounding the entire circumference of the treated sensory and sympathetic ganglia was a spectacularly dense, luxuriant, radial corona of nerve fibers—an optical phenomenon that Levi-Montalcini instantly christened the “halo”. Thousands of robust, parallel neurites emerged simultaneously from the ganglion, extending outward in all directions through the semi-solid plasma clot with breathtaking rapidity and structural density. The nerve fibers grew with such vigor that they appeared like the radiant rays of a miniature sun, forming an almost perfectly circular zone of fibrous density around the explant.

Crucially, this explosive axonal outgrowth occurred in the virtually total absence of migrating non-neuronal cells. Fibroblasts and satellite glial cells, which typically dominate embryonic ganglionic explants, were left far behind in the ganglionic core, while the neurites projected forward cleanly into the cell-free substrate. Furthermore, the neuritic halo formed uniformly across all 360 degrees of the ganglion’s margin, including the sector directed entirely away from the tumor fragment, confirming that the factor did not act merely as a directional beacon, but had saturated the local culture environment, unlocking an intrinsic, massive axonal growth program.

The creation of the hanging-drop halo bioassay was the master stroke of the entire NGF saga. By reducing an experimental process that previously required weeks of in ovo incubation, delicate embryo harvesting, histological processing, and serial counting down to a rapid, 24-hour visual assay, Levi-Montalcini created a standardized, semiquantitative biological measurement tool. Ganglionic response could now be graded on an arbitrary but reliable empirical scale (from 0 for no outgrowth, to 1+ for minor sprouting, to 4+ for the full, maximal, dense sunburst halo). This rapid bioassay was precisely what was required to guide a biochemist through the complex labyrinth of cellular fractionation.

7. Stanley Cohen’s Biochemical Partnership: Isolation and Characterization

7.1 The Interdisciplinary Union of Embryology and Biochemistry

Armed with the revolutionary Rio de Janeiro bioassay, Levi-Montalcini returned to Washington University in St. Louis in early 1953. Viktor Hamburger recognized that the research had reached a decisive transitional threshold: the embryological phenomena were fully documented, but uncovering the molecular identity of this mysterious “nerve growth agent” demanded a level of biochemical expertise that neither he nor Levi-Montalcini possessed. Hamburger immediately initiated a search for a skilled, creative biochemist capable of tackling an exceptionally difficult purification challenge: isolating trace quantities of a biologically active, unstable agent from complex mammalian neoplastic biomass.

The ideal collaborator was found in Stanley Cohen, an intellectually brilliant young biochemist who had completed his doctorate at the University of Michigan and conducted postdoctoral work on metabolic pathways and isotope chemistry at the University of Colorado. Cohen joined Hamburger’s laboratory in the Department of Zoology in 1953. The partnership forged between Levi-Montalcini and Cohen proved to be one of the most remarkably complementary and synergistic collaborations in modern biomedical history. Levi-Montalcini provided the biological intuition, the experimental vision, and the continuous execution of the rapid in vitro chick ganglion halo bioassay. Cohen brought absolute biochemical discipline, expertise in the latest protein fractionation methodologies, and an obsessive experimental rigor.

Their daily operational routine was an exercise in precision interdisciplinary coordination. Cohen would obtain kilograms of mouse Sarcoma 37 tumors (which had been found to produce even more consistent activity than Sarcoma 180), homogenize the malignant tissue, and subject the crude, turbid cellular lysates to systematic chemical fractionation steps. At every single stage of purification—every precipitation cut, every centrifugation supernatant, every chromatographic elution fraction—aliquots were immediately carried across the hall to Levi-Montalcini. Under sterile conditions, she would introduce these biochemical fractions into hanging-drop cultures of chick sensory ganglia. Within 18 to 24 hours, she would score the presence, absence, and intensity of the neuritic halo under the microscope, instantly reporting back to Cohen which specific fraction contained the active biological agent. Cohen defined one “Biological Unit” (BU) of activity as the minimum amount of protein per milliliter of culture medium required to elicit a maximal 4+ fibrillar halo.

7.2 Fractionation and Chemical Identity of the Tumor Factor

The biochemical fractionation of the mouse sarcoma extract was fraught with technical complexity. The active factor was present within the neoplastic cells in vanishingly small concentrations, mixed into a chaotic biochemical sea of thousands of structural proteins, metabolic enzymes, lipids, and nucleic acids. Cohen systematically applied the classical protein purification technologies of the era to progressively isolate the active principle.

First, the mouse Sarcoma 37 tumors were excised, stripped of necrotic debris, and homogenized in cold physiological saline. The crude homogenate was subjected to differential high-speed centrifugation to sediment insoluble membrane fragments and cellular organelles. To remove massive quantities of contaminating nucleic acids, Cohen treated the clear supernatant with streptomycin sulfate, which precipitated high-molecular-weight DNA and RNA complexes. Next, he subjected the soluble fraction to fractional ammonium sulfate ([NH₄]₂SO₄) precipitation, sequentially adding increasing concentrations of the salt to salt-out distinct protein populations based on their surface charge and hydrophobicity. The biological activity consistently precipitated within the 0.30 to 0.60 ammonium sulfate saturation cut.

The precipitated protein fraction was resuspended, dialyzed exhaustively against neutral buffers to remove residual salts, and subjected to ion-exchange column chromatography using newly developed diethylaminoethyl cellulose (DEAE-cellulose) resins. By systematically altering the pH and ionic strength of the elution buffer, Cohen successfully eluted the active factor, achieving a significant purification factor relative to the crude tumor lysate.

With partially purified fractions in hand, Cohen initiated crucial diagnostic enzymatic and biophysical experiments to determine the factor’s fundamental macromolecular class. Aliquots of the active fraction were incubated with crystalline proteolytic enzymes—specifically trypsin, chymotrypsin, and pepsin. Following enzymatic digestion, the samples were tested in Levi-Montalcini’s ganglionic bioassay; in every case, proteolytic digestion completely and irreversibly obliterated all halo-forming biological activity. Conversely, incubation of the active fraction with ribonuclease (RNase) or deoxyribonuclease (DNase)—enzymes that hydrolyze RNA and DNA—left the biological activity entirely intact.

Furthermore, Cohen demonstrated that the active agent was completely non-dialyzable through semi-permeable cellulose membranes, was rapidly destroyed by heating to 60 degrees Celsius for 30 minutes, and was completely inactivated by extreme acid or alkaline conditions. These experiments established an indisputable molecular reality: the tumor-derived nerve growth factor was not a steroid, lipid, small carbohydrate, or nucleic acid; it was an authentic, heat-labile, high-molecular-weight protein or nucleoprotein complex.

8. Unforeseen Abundance: Snake Venom and the Submandibular Gland

8.1 The Snake Venom Serendipity

Despite Cohen’s success in demonstrating that the sarcoma-derived factor was a protein, the overall yield remained minuscule. Kilograms of mouse tumors yielded only microgram quantities of partially purified material that still contained persistent, contaminating nucleic acid fragments. To resolve whether trace ribonucleic acids were playing an essential structural or catalytic role in the nucleoprotein complex, Cohen decided to employ a powerful enzymatic tool: phosphodiesterase, an enzyme capable of degrading the phosphodiester backbone of polynucleotides.

In 1956, the purest and most readily available commercial source of phosphodiesterase was snake venom. Cohen procured a sample of lyophilized venom from the moccasin snake (Agkistrodon piscivorus). His experimental design was classic in its biochemical logic: he would mix an aliquot of his partially purified Sarcoma 37 protein fraction with a small quantity of moccasin snake venom, incubate the mixture to allow the venom’s phosphodiesterase to completely hydrolyze any remaining nucleic acids, and then test the mixture in Levi-Montalcini’s ganglionic bioassay. If the halo still appeared, nucleic acids were definitively non-essential. To maintain strict experimental control, Cohen included a crucial negative control tube containing only the snake venom dissolved in buffer, without any tumor extract.

The following morning, Levi-Montalcini inspected the tissue culture slides under her microscope. What she observed was an empirical shock that instantly altered the entire trajectory of their research. The experimental cultures containing the tumor extract plus snake venom showed an unfathomably dense, hypertrophic halo of nerve fibers. But the control slides—the slides that contained the snake venom alone—did not produce a blank, flat negative field. Instead, the snake venom by itself had elicited a staggering, colossal 4+ halo. The neuritic outgrowth was so explosive and thick that it surpassed any response ever provoked by the most concentrated tumor extracts.

When Cohen and Levi-Montalcini quantified this startling phenomenon, they discovered that crude snake venom possessed a specific nerve-growth-promoting biological activity that was thousands of times higher, per microgram of protein, than their most purified sarcoma extracts. The snake venom was not merely a convenient source of phosphodiesterase; it was an astonishing, concentrated reservoir of Nerve Growth Factor itself. Subsequent assays revealed that the venoms of diverse viperid, crotalid, and elapid snake species—including the cobras Naja naja and Bitis arietans—contained similar hyper-concentrations of the factor, proving that the nerve growth molecule was an evolutionarily ancient, deeply conserved biological agent.

8.2 The Male Mouse Submandibular Gland as a Hyper-Source

The snake venom discovery, while breathtaking, presented practical and theoretical puzzles. Snake venom is a highly toxic, complex cocktail of neurotoxins, hemotoxins, and lethal proteolytic enzymes, making it dangerous to work with in large volumes and conceptually difficult to reconcile with mammalian neuroembryology. Why would a lethal ophidian venom gland produce a specialized protein that specifically stimulates the sensory and sympathetic neurons of an embryonic bird?

Stanley Cohen reflected deeply upon the comparative evolutionary anatomy of the venom apparatus. In snakes, venom glands are specialized, modified exocrine organs that are phylogenetically and morphologically homologous to the mammalian salivary glands. Cohen formulated an intuitive hypothesis: if the modified salivary glands of reptiles synthesize massive quantities of Nerve Growth Factor, could the ordinary salivary glands of mammals also produce the molecule?

In 1958, Cohen obtained salivary glands from adult laboratory mice. He meticulously dissected the major pairs: the parotid glands, the sublingual glands, and the submandibular (submaxillary) glands. He homogenized the tissues, centrifuged the lysates, and brought the dialyzed supernatants to Levi-Montalcini for testing in her chick ganglion bioassay.

The biological response was immediate and overwhelming. While extracts from the parotid and sublingual glands exhibited negligible activity, the homogenates derived from the submandibular salivary glands of mice produced massive, classical 4+ fibrillar halos at staggering dilutions. Cohen had uncovered a biological goldmine: the submandibular gland of the common house mouse contained concentrations of Nerve Growth Factor that were more than ten thousand times greater than those found in Sarcoma 37, and many times greater than the highest concentrations found in snake venom.

Furthermore, Cohen and Levi-Montalcini quickly discovered a striking, highly informative physiological phenomenon: the presence of NGF within the submandibular gland was characterized by profound sexual dimorphism. Extracts prepared from adult male mice exhibited significantly higher concentrations of NGF than extracts prepared from adult female mice. Cohen demonstrated that this sexual dimorphism was directly governed by endocrine signaling: castration of adult male mice resulted in a drastic drop in submandibular gland NGF levels, whereas the daily administration of exogenous testosterone to female or castrated male mice dramatically upregulated NGF synthesis, transforming the female glands into hyper-producers of the factor.

The discovery of the male mouse submandibular gland as a hyper-abundant source of NGF permanently transformed the field. No longer were Levi-Montalcini and Cohen constrained by the agonizing, low-yield harvest of kilograms of malignant mouse tumors. The mouse submandibular gland provided an accessible, inexhaustible, highly concentrated biological starting material, making large-scale biochemical purification, crystallization, structural sequencing, and physiological in vivo experimentation an immediate, practical reality.

9. Elucidation of the Molecular Structure and Mechanism of NGF

9.1 Structural Biochemistry of the 7S and 2.5S NGF Complexes

With an abundant supply of submandibular gland tissue, Stanley Cohen and subsequent generations of protein biochemists initiated the rigorous structural characterization of the NGF molecule. Through multi-step purification protocols involving streptomycin precipitation, ammonium sulfate cuts, and column chromatography on carboxymethyl-cellulose (CM-cellulose) and DEAE-cellulose, Cohen successfully isolated the native protein to near homogeneity.

Subsequent biophysical investigations—led extensively by biochemists such as Silvio Varon, Eric Shooter, and Ralph Bradshaw—revealed that native Nerve Growth Factor exists within the mouse submandibular gland not as an isolated polypeptide, but as a high-molecular-weight, multi-subunit quaternary protein complex possessing a sedimentation coefficient of approximately 7S (molecular weight approximately 130,000 to 140,000 Daltons). This macromolecular complex, designated as 7S NGF, was found to be a stable, non-covalently linked hexamer composed of three distinct polypeptide subunit types designated as alpha (α), beta (β), and gamma (γ), structured in an α₂βγ₂ stoichiometry, held together by coordinated central zinc ions (Zn²⁺).

Biochemical dissection of the 7S complex revealed a remarkable division of physiological labor among its constituent subunits:

• The Alpha Subunit (α-NGF): An inactive member of the glandular kallikrein family of serine proteases that functions as a structural chaperone, lacking any intrinsic neurotrophic biological activity.
• The Gamma Subunit (γ-NGF): An active, highly specific serine protease, also belonging to the kallikrein family, responsible for the precise endoproteolytic processing and cleavage of the inactive precursor form of NGF (pro-NGF) into its biologically active configuration.
• The Beta Subunit (β-NGF): The sole repository of all neurotrophic, halo-producing biological activity. When dissociated from the 7S complex through exposure to extreme pH or chelating agents that strip away the coordinating zinc ions, the β subunit alone (frequently designated as 2.5S NGF based on its sedimentation coefficient) retains the complete capacity to stimulate sensory and sympathetic neurons.

The active β-NGF molecule was determined to be a tightly bound, non-covalent homodimer with a molecular mass of approximately 26,500 Daltons. In 1971, Ruth Hogue Angeletti and Ralph Bradshaw accomplished the monumental task of elucidating the primary amino acid sequence of the 2.5S β-NGF monomer. The polypeptide chain was found to consist of exactly 118 amino acids, characterized by an exceptionally high isoelectric point (pI ~ 9.3), reflecting an abundance of basic residues (arginine and lysine). The primary sequence is stabilized by three intramyocellular, highly conserved covalent disulfide bonds (bridges formed between Cys15–Cys80, Cys58–Cys108, and Cys68–Cys110). Later X-ray crystallographic studies conducted by Tom Blundell and colleagues revealed that these disulfide bonds form a unique structural architecture known as a “cystine knot” motif—a structural signature that defined NGF as the founding member of the cystine-knot superfamily of growth factors.

9.2 Cellular Mechanisms and Receptor Signaling Paradigms

The molecular identification of NGF immediately raised the fundamental mechanistic question: how does an extracellular, target-derived protein, captured by an axonal terminal situated centimeters or even meters away from the neuronal soma, transmit its life-sustaining, gene-regulatory instructions backward to the cell nucleus?

The answer emerged through the conceptualization and experimental verification of the retrograde signaling endosome hypothesis, developed by researchers including Ian Hendry, Hans Thoenen, and William Mobley. When the active β-NGF homodimer is secreted by target tissues in limiting, nanomolar concentrations, it binds to two distinct, specialized cell-surface receptor proteins located on the plasma membrane of the axonal growth cone:

1. TrkA (Tropomyosin receptor kinase A): A high-affinity (K_d ≈ 10^-11 M) receptor tyrosine kinase discovered in the late 1980s and early 1990s by Mariano Barbacid and colleagues. The binding of the β-NGF homodimer induces the rapid physical dimerization of two adjacent TrkA monomers. Dimerization brings their intracellular kinase domains into direct apposition, triggering trans-autophosphorylation of specific regulatory tyrosine residues (e.g., Tyr490, Tyr751, Tyr785) within the cytoplasmic tail.

2. p75NTR: The low-affinity (K_d ≈ 10^-9 M) pan-neurotrophin receptor, a member of the Tumor Necrosis Factor (TNF) receptor superfamily. p75NTR lacks an intrinsic enzymatic kinase domain. Instead, it cooperates with TrkA to form high-affinity binding sites, modulates the kinetics of NGF binding, and, under specific cellular contexts, independently engages intracellular death domains to trigger apoptosis via JNK kinase cascades or activate survival pathways through NF-κB.

Upon TrkA activation and autophosphorylation at the axonal terminal, the ligand-receptor complex—consisting of the NGF dimer bound to phosphorylated TrkA—is rapidly internalized through clathrin-mediated endocytosis into specialized vesicles termed “signaling endosomes.” These signaling endosomes retain catalytic activity: the TrkA kinase remains phosphorylated and active within the endosomal membrane. The endosome then associates with cytoplasmic retrograde molecular motors, specifically the retrograde motor complex dynein, and is transported retrogradely along axonal microtubules over long anatomical distances toward the neuronal perikaryon.

Upon reaching the cell body, the retrograde signaling endosome initiates robust, persistent downstream intracellular signaling cascades. Phosphorylated tyrosine residues on TrkA recruit specific intracellular adaptor proteins containing SH2 and PTB domains, activating three primary intracellular pathways:

• The PI3K / Akt Pathway: Initiated via recruitment of Gab1 and PI3-kinase, generating PIP₃, which activates the serine/threonine kinase Akt (Protein Kinase B). Akt directly phosphorylates and inactivates the pro-apoptotic Bcl-2 family member Bad, inhibits the transcription factor FoxO, and suppresses the activation of executioner caspases, thereby directly executing the fundamental trophic mandate of cell survival.
• The Ras / MAPK / ERK Cascade: Recruits the Shc-Grb2-Sos complex, converting inactive Ras-GDP to active Ras-GTP, which initiates the sequential kinase cascade of Raf, MEK, and ERK1/2. Phosphorylated ERK translocates into the nucleus, where it phosphorylates and activates critical transcription factors, notably CREB (cAMP response element-binding protein), which directly upregulates the transcription of neuroprotective genes, including Bcl-2, and drives prolonged axonal outgrowth.
• The PLC-γ Pathway: Phospholipase C-gamma hydrolyzes membrane phosphatidylinositol 4,5-bisphosphate (PIP₂) to generate inositol trisphosphate (IP₃) and diacylglycerol (DAG), mobilizing intracellular calcium stores from the endoplasmic reticulum and activating Protein Kinase C (PKC), which modulates growth cone motility and local cytoskeletal dynamics.

10. The Immunosympathectomy Experiment: The Definitive Proof

10.1 Generation and Delivery of Anti-NGF Antibodies

By the late 1950s, Rita Levi-Montalcini and Stanley Cohen had demonstrated that exogenous NGF, isolated from sarcomas, snake venoms, or salivary glands, could force the massive hyper-trophy and survival of sensory and sympathetic neurons both in vitro and in vivo. However, a critical scientific question remained unanswered. Skeptics, particularly those within classical endocrinology and embryology, raised an objection: was Nerve Growth Factor merely an interesting, highly potent pharmacological oddity—an exogenous biological poison or super-stimulant—or was it an authentic, indispensable, endogenous physiological hormone required for the normal life and survival of neurons in a living mammal?

To definitively resolve this question, Stanley Cohen conceived an experiment based on immunological neutralization. If endogenous NGF was truly an absolute requirement for the development and maintenance of the sympathetic nervous system, then the systemic removal or destruction of native NGF within an intact, developing animal should theoretically result in the spontaneous death and disappearance of that exact neuronal population.

In 1959, Cohen injected rabbits with repeated doses of purified submandibular mouse NGF emulsified with Freund’s adjuvant. The rabbit immune systems recognized the mouse protein as a foreign antigen, mounting a massive humoral immune response. Cohen harvested the rabbit blood, separated the serum, and subjected it to systematic immunological testing. The resulting rabbit anti-NGF antiserum possessed high titers of polyclonal neutralizing antibodies capable of completely neutralizing the biological halo-forming activity of NGF in Levi-Montalcini’s chick ganglion culture assays.

Together, Levi-Montalcini and Cohen planned an in vivo administration protocol. They selected newborn mammals—specifically neonatal mice and rats—during the critical developmental window when their peripheral sympathetic nervous systems were undergoing target-dependent maturation. Experimental neonatal rodents received daily subcutaneous injections of tiny volumes of the rabbit anti-NGF antiserum over a period of several consecutive days immediately following birth. Parallel control litters received identical injections of non-immune, normal rabbit serum.

10.2 Total Ablation of the Sympathetic Nervous System

The biological outcome of these experiments was staggering. The administration of the anti-NGF antiserum produced what Levi-Montalcini permanently termed “immunosympathectomy”—the almost total, clean, and irreversible chemical ablation of the sympathetic nervous system, achieved without surgical trauma, physical damage, or toxic injury to non-neural somatic tissues.

When Levi-Montalcini histologically examined the treated animals, she discovered that the entire paravertebral and prevertebral sympathetic chain ganglia—including the superior cervical, stellate, thoracic, mesenteric, and lumbar ganglia—had been almost completely eradicated. Within days of initiating the antiserum injections, the sympathetic neuroblasts underwent massive, synchronous, and catastrophic pyknotic degeneration. Under the light microscope, the once-dense, cellular sympathetic ganglia were reduced to microscopic, ghost-like fibrous scars composed almost exclusively of empty connective tissue stroma and a few surviving non-neuronal satellite glial cells. More than 95 to 99 percent of the mature sympathetic neurons had been entirely deleted from the organism.

Equally critical was the exquisite specificity of this destruction. The animals survived the treatment and exhibited normal body weight gain, skeletal growth, and behavioral vigor. Histological examination of other nervous system structures revealed that the central nervous system (the brain and spinal cord) was completely unharmed. The somatic motor neurons of the ventral horn, which control skeletal muscle, were entirely normal. The sensory dorsal root ganglia, which had responded to NGF during earlier embryonic stages, were no longer sensitive to the antiserum during this late neonatal period and remained intact. Furthermore, within the endocrine system, the chromaffin cells of the adrenal medulla—which are embryologically derived from the identical neural crest lineage as sympathetic neurons—were completely spared from destruction, protected by their specialized endocrine microenvironment.

The immunosympathectomy experiments, published in the early 1960s in journals such as the Proceedings of the National Academy of Sciences, provided the definitive, unshakeable proof that silenced every remaining critic. Endogenous Nerve Growth Factor was not a dispensable stimulator or an experimental curiosity; it was an absolute, non-negotiable physiological requirement for the survival of the sympathetic nervous system. The Neurotrophic Factor Hypothesis was thus elevated from an inspired, controversial conjecture to an established foundational law of neurobiology.

11. The 1986 Nobel Prize and Conceptual Paradigm Shifts

11.1 The Long Path to Formal Recognition

Despite the undeniable triumph of the immunosympathectomy experiments, universal academic recognition and the ultimate scientific accolades did not arrive overnight. For decades, Rita Levi-Montalcini and Stanley Cohen’s discoveries occupied an anomalous position within the broader biological sciences. In the 1960s and 1970s, the burgeoning fields of molecular biology and biochemistry were dominated by the study of bacterial genetics, the genetic code, and the central dogma of DNA and RNA. Within this intellectual milieu, growth factors were frequently viewed with deep suspicion—regarded as complex, messy phenotypic phenomena lacking the clean, universal reductionist beauty of microbial genetics.

Many mainstream biochemists were perplexed by the strange, seemingly erratic tissue distribution of NGF. Why should a nerve growth factor be found in astronomical concentrations within snake venoms and the submandibular salivary glands of male mice, while remaining present in only vanishing, barely detectable picomolar traces within the actual target tissues and brains of higher mammals? To some conservative critics, this bizarre evolutionary distribution suggested that NGF was merely an esoteric salivary byproduct rather than a universal biological organizer.

This academic skepticism began to crumble as Stanley Cohen systematically proved that the discovery of NGF was not an isolated, idiosyncratic anomaly, but the first glimpse into an entirely new continent of cell biology. Following his departure from Washington University to Vanderbilt University in 1959, Cohen isolated an unexpected second biological factor from the male mouse submandibular gland: a heat-stable, low-molecular-weight protein that accelerated incisor tooth eruption and precocious eyelid opening in neonatal rodents. This molecule was Epidermal Growth Factor (EGF). Cohen subsequently purified EGF, sequenced it, characterized the EGF receptor (EGFR), and demonstrated that its receptor possessed intrinsic ligand-activated tyrosine kinase activity—a discovery that unified the study of growth factors directly with the molecular mechanisms of oncogenesis and cancer cell signaling.

With the discovery of EGF and the subsequent identification of platelet-derived growth factor (PDGF), fibroblast growth factors (FGF), and insulin-like growth factors (IGF), the scientific world finally recognized that Levi-Montalcini and Cohen had discovered the archetype for intercellular communication across all metazoan life. In October 1986—more than thirty-five years after the initial Sarcoma 180 transplantations in chick embryos—the Nobel Assembly at the Karolinska Institute awarded the Nobel Prize in Physiology or Medicine jointly to Rita Levi-Montalcini and Stanley Cohen “for their discoveries of growth factors.”

The awarding of the Nobel Prize carried immense historical, emotional, and social resonance. Rita Levi-Montalcini became only the fourth woman to receive the Nobel Prize in Physiology or Medicine. Her triumph was a monumental historical vindication: a Jewish woman scientist who had pursued her research in total academic exile, working in a clandestine bedroom laboratory while fleeing Fascist racial persecution and Nazi occupation, had fundamentally altered humanity’s understanding of the living brain.

11.2 Shift from Static to Dynamic Concepts of Neural Connectivity

The conceptual ramifications of the discovery of NGF extended far beyond the immediate identification of a single signaling protein. It fundamentally dismantled the rigid, pre-deterministic, and static views of the nervous system that had reigned supreme since the late nineteenth century. Before NGF, neurogenesis was viewed as a strict, forward-directed assembly line: genes dictated the production of neurons, neurons extended axons along structural mechanical planes, and connections were hardwired according to unyielding genetic instructions.

The discovery of NGF introduced the revolutionary concept of retrograde signaling—the principle that the periphery actively talks back to the center, sculpting its own neural inputs. The architecture of the nervous system was revealed to be dynamic, competitive, and plastic. The brain does not develop via an immaculate blueprint wherein every cell is guaranteed survival. Instead, development relies upon an evolutionary, Darwinian strategy operating at the cellular level: the organism systematically overproduces neural precursor units, and these cells are forced to compete for limiting, scarce quantities of trophic resources continuously supplied by the target field.

This insight fundamentally transformed the scientific understanding of programmed cell death (apoptosis). Prior to Levi-Montalcini’s work, cellular death in biology was universally viewed through a pathological lens—the consequence of toxic necrosis, metabolic catastrophe, hypoxia, or physical trauma. Levi-Montalcini established that physiological cell suicide is an essential, healthy, and indispensable design principle of normal embryogenesis. Cell death is the default programmatic state of the immature neuron; it is only held at bay through the continuous, target-derived interception of trophic survival signals. This realization laid the direct conceptual foundation for the modern molecular dissection of apoptotic signaling pathways, caspases, and the Bcl-2 protein family.

Furthermore, the discovery of NGF transformed developmental embryology into modern molecular cell biology and neurobiology. It bridged the historical chasm between macroscopic anatomical observation and microscopic chemical mechanics, proving that complex anatomical patterns are orchestrated by precise, nanomolar chemical gradients acting upon specific, high-affinity cell-surface receptor tyrosine kinases.

12. Translational Legacy and Contemporary Frontiers in Neurotrophin Biology

12.1 The Neurotrophin Family and Central Nervous System Complexity

For nearly three decades following its identification, NGF stood as an isolated molecular oddity—the only known neurotrophic factor. However, the profound biological principles unveiled by Levi-Montalcini and Cohen suggested that other neuronal populations—particularly those residing within the immensely complex architecture of the mammalian Central Nervous System (CNS)—must rely on analogous, target-derived trophic molecules.

This hypothesis was definitively validated in 1982, when German neurobiologist Yves-Alain Barde and his colleagues, working at the Max Planck Institute for Psychiatry in Martinsried, accomplished the grueling purification of the second neurotrophic factor from mammalian brain tissue: Brain-Derived Neurotrophic Factor (BDNF). When the primary structure of BDNF was cloned and sequenced in 1989, it revealed an unmistakable, high-degree sequence homology and structural identity with Levi-Montalcini’s β-NGF, including the exact conservation of the three crucial cystine-knot disulfide bonds.

The cloning of BDNF ignited an explosive molecular gold rush that rapidly led to the identification of a structurally unified neurotrophin family in mammals, comprising four primary canonical members:

• Nerve Growth Factor (NGF): Primarily acting via its cognate high-affinity receptor TrkA, controlling sympathetic neurons, neural crest-derived sensory nociceptive neurons, and basal forebrain cholinergic neurons.
• Brain-Derived Neurotrophic Factor (BDNF): Signaling primarily through the receptor tyrosine kinase TrkB, serving as a master regulator of synaptic plasticity, long-term potentiation (LTP), dendritic arborization, and cognitive processing throughout the hippocampus and cerebral cortex.
• Neurotrophin-3 (NT-3): Signaling primarily via TrkC (and to a lesser extent TrkA and TrkB), fulfilling indispensable roles in the survival and axonal guidance of large-diameter sensory proprioceptive neurons and spinal motor circuits.
• Neurotrophin-4/5 (NT-4/5): An additional specific ligand for the TrkB receptor, contributing to sensory neuron survival and neuromuscular system maintenance.

The discovery of the neurotrophin family radically reshaped central neurobiology. Neurotrophins were shown to do far more than merely sustain embryonic cell survival; they are active, dynamic regulators of the adult brain. BDNF, in particular, has emerged as a central currency of synaptic strength and cognitive function. It is synthesized and released in an activity-dependent manner at excitatory synapses, where it binds to postsynaptic TrkB receptors to drive the phosphorylation of NMDA receptor subunits, facilitate AMPA receptor insertion into the postsynaptic density, and stimulate local dendritic protein synthesis—the fundamental cellular substrates of learning, memory, and cognitive adaptation.

Consequently, dysregulation of the neurotrophin-Trk receptor signaling network is now recognized as a primary pathological driver across a vast spectrum of psychiatric and neurological disorders. Profound deficits in BDNF expression and downstream TrkB-Akt/ERK signaling are deeply implicated in the etiology of major depressive disorder (MDD), bipolar disorder, and chronic stress-induced hippocampal atrophy. Indeed, modern psychiatric pharmacology has revealed that the therapeutic efficacy of selective serotonin reuptake inhibitors (SSRIs) and rapid-acting antidepressants like ketamine is directly mediated by the retroactive upregulation of BDNF synthesis and the direct facilitation of TrkB signaling within cortical and limbic circuits.

12.2 Therapeutic Innovations and Clinical Hurdles

The clinical application of Rita Levi-Montalcini and Stanley Cohen’s discoveries has expanded into an active frontier of translational medicine, encompassing the treatment of neurodegenerative diseases, ophthalmological pathologies, and intractable chronic pain states. However, translating the powerful biological actions of neurotrophins into effective human therapeutics has encountered significant pharmacological challenges.

In the realm of chronic pain, the NGF/TrkA axis has emerged as one of the most clinically validated therapeutic targets in modern pharmacology. During adult life, NGF ceases to function primarily as an indispensable survival factor for sensory neurons; instead, it becomes a powerful, hyper-sensitizing pro-inflammatory mediator. Secreted by immune cells (mast cells, macrophages) and damaged tissues during inflammation, NGF binds to TrkA receptors on peripheral nociceptive (pain-sensing) nerve fibers, inducing both rapid sensitization of ion channels (such as TRPV1) and the long-term transcriptional upregulation of pain-transmitting neuropeptides like Substance P and CGRP.

To interrupt this pathological cascade, pharmaceutical developers created humanized monoclonal antibodies designed to capture and neutralize circulating NGF with exquisite specificity. The most prominent of these agents, Tanezumab, demonstrated remarkable, unprecedented efficacy in phase III clinical trials, providing profound relief from chronic, debilitating pain in patients suffering from severe osteoarthritis and chronic lower back pain. By stripping NGF from the inflamed joint microenvironment, Tanezumab effectively reversed peripheral nociceptive hypersensitivity without the addiction risks and systemic side effects associated with opioid narcotics, although clinical deployment has required careful risk-benefit evaluation regarding accelerated joint destruction in specific patient subsets.

Conversely, the regenerative, tissue-repair properties of NGF have achieved stunning success in human ophthalmology. In conditions such as neurotrophic keratitis—a rare, devastating degenerative disease of the eye characterized by the loss of corneal sensory innervation, leading to chronic epithelial breakdown, corneal ulceration, stromal melting, and irreversible blindness—the therapeutic challenge was to restore trophic support to the damaged sensory fibers of the trigeminal nerve. In 2017 and 2018, regulatory agencies approved Cenegermin (Oxervate), a topical ophthalmic solution containing recombinant human Nerve Growth Factor (rhNGF). When applied directly to the human eye, Cenegermin acts locally upon TrkA receptors on corneal epithelial cells and sensory nerve endings, stimulating the complete re-innervation, healing, and structural restoration of the human cornea—representing the very first recombinant neurotrophic factor drug approved for clinical use in human medicine.

Despite these triumphs, translating neurotrophins to neurodegenerative diseases of the central nervous system—such as Alzheimer’s disease and Parkinson’s disease—has faced formidable physiological barriers. In Alzheimer’s disease, the basal forebrain cholinergic neurons (BFCNs), which play an essential role in attention and spatial memory, undergo progressive, severe degeneration. These specific cholinergic neurons uniquely express both TrkA and p75NTR throughout adult life and are completely dependent upon retrograde NGF transport from the hippocampus and cerebral cortex for their maintenance. Early clinical attempts to administer recombinant NGF systemically or via intravenous injection failed completely because NGF, as a massive hydrophilic protein dimer (~26 kDa), is absolutely incapable of crossing the tight junctions of the blood-brain barrier (BBB). Furthermore, systemic delivery triggered severe peripheral side effects, including intense myalgias and unselective pain hypersensitivity.

To overcome this hurdle, contemporary translational frontiers utilize advanced, targeted biotechnology delivery platforms. Clinical researchers have pioneered the use of gene therapy vectors—specifically non-replicating adeno-associated virus (AAV) vectors engineered to carry the human β-NGF gene (AAV2-NGF). Utilizing stereotactic neurosurgery guided by high-resolution magnetic resonance imaging, these viral vectors are injected directly into the basal forebrain of Alzheimer’s patients, specifically targeting the nucleus basalis of Meynert. The transduced cells continuously synthesize and secrete physiological, localized levels of recombinant NGF directly into the local parenchymal microenvironment, successfully providing sustained, localized neurotrophic support to the degenerating cholinergic fibers without entering the systemic bloodstream.

Parallel strategies employ encapsulated cell biodelivery (ECB) systems, in which human cells genetically engineered to produce human NGF are sealed within semi-permeable, immunoprotective polymer capsules. These microscopic biological factories are surgically implanted into the human brain parenchyma, where they continuously secrete NGF across the capsule membrane while remaining completely shielded from host immune rejection. Through these engineering feats, the fragile, diffusible molecule first observed in a domestic bedroom laboratory in Turin continues to redefine the cutting edge of molecular medicine and cellular therapeutics.

Conclusion

The discovery of Nerve Growth Factor stands as an enduring monument to scientific perseverance, experimental ingenuity, and interdisciplinary collaboration. In tracing the arc of this discovery—from Rita Levi-Montalcini’s improvised, clandestine laboratory in Fascist Italy to the dynamic partnership with Stanley Cohen at Washington University—one witnesses how fearless, rigorous observation shattered decades of entrenched, dogmatic paradigms. Where the scientific consensus saw only mechanical constraints, contact guidance, and deterministic developmental templates, Levi-Montalcini looked with uncompromising histological clarity and perceived a universe of dynamic, chemical communication.

The subsequent isolation, characterization, and molecular cloning of NGF revealed the universal language of trophic signaling, fundamentally rewriting our understanding of cellular life, developmental competition, and programmed cell death. By proving that the peripheral target actively dictates the survival and architecture of its innervating neural networks through the retrograde delivery of limiting, diffusible chemical messengers, Levi-Montalcini and Cohen did not merely discover a single growth factor; they uncovered an entirely new dimension of biological regulation.

Today, the ripples of that paradigm shift continue to expand across modern biomedicine. The neurotrophic concept has become a guiding light in our quest to understand synaptic plasticity, decode the complex etiology of neuropsychiatric disorders, and develop next-generation molecular therapies for chronic pain, corneal blindness, and neurodegenerative disease. The legacy of Rita Levi-Montalcini and Stanley Cohen remains an inspiring testament to the power of human curiosity and experimental rigor—a brilliant reminder that the most revolutionary, transformative insights in science often begin by daring to question the prevailing orthodoxies of the day.

References

• Angeletti, R. H., & Bradshaw, R. A. (1971). Nerve growth factor from mouse submaxillary gland: Amino acid sequence. Proceedings of the National Academy of Sciences, 68(10), 2417–2420. https://doi.org/10.1073/pnas.68.10.2417
• Barde, Y. A., Edgar, D., & Thoenen, H. (1982). Purification of a new neurotrophic factor from mammalian brain. The EMBO Journal, 1(5), 549–553. https://doi.org/10.1002/j.1460-2075.1982.tb01207.x
• Bueker, E. D. (1948). Implantation of tumors in the hind limb field of the embryonic chick and its effect on the spinal cord. The Anatomical Record, 102(3), 369–389. https://doi.org/10.1002/ar.1091020307
• Cajal, S. R. y. (1893). La rétine des vertébrés. La Cellule, 9, 119–257.
• Chao, M. V. (2003). Neurotrophins and their receptors: A convergence point for many signalling pathways. Nature Reviews Neuroscience, 4(4), 299–309. https://doi.org/10.1038/nrn1078
• Cohen, S. (1960). Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proceedings of the National Academy of Sciences, 46(3), 302–311. https://doi.org/10.1073/pnas.46.3.302
• Cohen, S., & Levi-Montalcini, R. (1956). A nerve growth-stimulating factor isolated from snake venom. Proceedings of the National Academy of Sciences, 42(9), 571–574. https://doi.org/10.1073/pnas.42.9.571
• Hamburger, V. (1934). The effects of wing bud extirpation on the development of the central nervous system in chick embryos. Journal of Experimental Zoology, 68(3), 449–494. https://doi.org/10.1002/jez.1400680305
• Hamburger, V., & Levi-Montalcini, R. (1949). Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. Journal of Experimental Zoology, 111(3), 457–501. https://doi.org/10.1002/jez.1401110308
• Harrison, R. G. (1907). Observations on the living developing nerve fiber. The Anatomical Record, 1(5), 116–118. https://doi.org/10.1002/ar.1090010503
• Huang, E. J., & Reichardt, L. F. (2001). Neurotrophins: Roles in neuronal development and function. Annual Review of Neuroscience, 24(1), 677–736. https://doi.org/10.1146/annurev.neuro.24.1.677
• Levi-Montalcini, R. (1952). Effects of mouse tumor transplants on the nervous system. Annals of the New York Academy of Sciences, 55(2), 330–344. https://doi.org/10.1111/j.1749-6632.1952.tb26548.x
• Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science, 237(4819), 1154–1162. https://doi.org/10.1126/science.3306916
• Levi-Montalcini, R., & Booker, B. (1960). Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein. Proceedings of the National Academy of Sciences, 46(3), 384–391. https://doi.org/10.1073/pnas.46.3.384
• Levi-Montalcini, R., & Cohen, S. (1960). Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals. Annals of the New York Academy of Sciences, 85(1), 324–341. https://doi.org/10.1111/j.1749-6632.1960.tb49964.x
• Levi-Montalcini, R., & Hamburger, V. (1951). Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic system of the chick embryo. Journal of Experimental Zoology, 116(2), 321–361. https://doi.org/10.1002/jez.1401160206
• Levi-Montalcini, R., & Hamburger, V. (1953). A diffusable agent of mouse sarcomas, producing hyperplasia of sympathetic ganglia and hyperneurotization of viscera in the chick embryo. Journal of Experimental Zoology, 123(2), 233–287. https://doi.org/10.1002/jez.1401230203
• Levi-Montalcini, R., & Levi, G. (1942). Les conséquences de la destruction d’un territoire d’innervation périphérique sur le développement des centres nerveux correspondants dans l’embryon de poulet. Archives de Biologie, 53, 537–545.
• McDonald, N. Q., Lapatto, R., Murray-Rust, J., Gunning, J., Wlodawer, A., & Blundell, T. L. (1991). New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor. Nature, 354(6352), 411–414. https://doi.org/10.1038/354411a0
• Purves, D., & Lichtman, J. W. (1985). Principles of Neural Development. Sinauer Associates.
• Shooter, E. M. (2001). Early days of the nerve growth factor proteins. Annual Review of Neuroscience, 24(1), 601–629. https://doi.org/10.1146/annurev.neuro.24.1.601
• Shorey, M. L. (1909). The effect of the destruction of peripheral areas on the differentiation of the neuroblasts. Journal of Experimental Zoology, 7(1), 25–63. https://doi.org/10.1002/jez.1400070103
• Weiss, P. (1934). In vitro experiments on the factors determining the course of the outgrowing nerve fiber. Journal of Experimental Zoology, 68(3), 393–448. https://doi.org/10.1002/jez.1400680304
• Weiss, P. (1941). Nerve patterns: The mechanics of nerve growth. Third Growth Symposium, 5, 163–203.